<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en" dir="ltr">
  <head>
    <meta http-equiv="Content-Type" content="text/html; charset=UTF-8" />
    		<meta name="keywords" content="Antiphospholipid syndrome,AIDS,Anne of Great Britain,Antibody,Anticoagulant,Antigen,Antithrombin,Artery,Aspirin,Autoimmune disease,Autoimmune disorder" />
		<link rel="shortcut icon" href="/favicon.ico" />
		<link rel="search" type="application/opensearchdescription+xml" href="/w/opensearch_desc.php" title="Wikipedia (English)" />
		<link rel="copyright" href="../../../COPYING.html" />
    <title>Antiphospholipid syndrome - Wikipedia, the free encyclopedia</title>
    <style type="text/css">/*<![CDATA[*/ @import "../../../skins/htmldump/main.css"; /*]]>*/</style>
    <link rel="stylesheet" type="text/css" media="print" href="../../../skins/common/commonPrint.css" />
    <!--[if lt IE 5.5000]><style type="text/css">@import "../../../skins/monobook/IE50Fixes.css";</style><![endif]-->
    <!--[if IE 5.5000]><style type="text/css">@import "../../../skins/monobook/IE55Fixes.css";</style><![endif]-->
    <!--[if IE 6]><style type="text/css">@import "../../../skins/monobook/IE60Fixes.css";</style><![endif]-->
    <!--[if IE]><script type="text/javascript" src="../../../skins/common/IEFixes.js"></script>
    <meta http-equiv="imagetoolbar" content="no" /><![endif]-->
    <script type="text/javascript" src="../../../skins/common/wikibits.js"></script>
    <script type="text/javascript" src="../../../skins/htmldump/md5.js"></script>
    <script type="text/javascript" src="../../../skins/htmldump/utf8.js"></script>
    <script type="text/javascript" src="../../../skins/htmldump/lookup.js"></script>
    <script type="text/javascript" src="../../../raw/gen.js"></script>        <style type="text/css">/*<![CDATA[*/
@import "../../../raw/MediaWiki%7ECommon.css";
@import "../../../raw/MediaWiki%7EMonobook.css";
@import "../../../raw/gen.css";
/*]]>*/</style>          </head>
  <body
    class="ns-0">
    <div id="globalWrapper">
      <div id="column-content">
	<div id="content">
	  <a name="top" id="contentTop"></a>
	        <h1 class="firstHeading">Antiphospholipid syndrome</h1>
	  <div id="bodyContent">
	    <h3 id="siteSub">From Wikipedia, the free encyclopedia</h3>
	    <div id="contentSub"></div>
	    	    	    <!-- start content -->
	    <div class="messagebox cleanup metadata plainlinks"><b>This article or section does not adequately cite its <a href="../../../c/i/t/Wikipedia%7ECiting_sources_8ba4.html" title="Wikipedia:Citing sources">references or sources</a>.</b><br />
<small>Please help <a href="http://en.wikipedia.org../../../a/n/t/Antiphospholipid_syndrome.html" class="external text" title="http://en.wikipedia.org../../../a/n/t/Antiphospholipid_syndrome.html" rel="nofollow">improve this article</a> by adding citations to <a href="../../../a/t/t/Wikipedia%7EAttribution_916a.html" title="Wikipedia:Attribution">reliable sources</a>. (<a href="../../../c/o/n/Help%7EContents_22de.html" title="Help:Contents">help</a>, <a href="../../../w/i/k/Wikipedia%7EWikiProject_Fact_and_Reference_Check_47bc.html" title="Wikipedia:WikiProject Fact and Reference Check">get involved!</a>)<br />
Any material not supported by sources may be challenged and removed at any time. This article has been tagged since <b>March 2007</b>.</small></div>
<table class="infobox" style="width: 200px; font-size: 95%; text-align: left;">
<caption style="background: lightgrey; font-size: 95%;"><b>Antiphospholipid syndrome</b><br />
<i>Classification &amp; external resources</i></caption>
<tr>
<th><a href="../../../i/c/d/ICD_10d0.html" title="ICD">ICD</a>-<a href="../../../l/i/s/List_of_ICD-10_codes_1183.html" title="List of ICD-10 codes">10</a></th>
<td><a href="../../../i/c/d/ICD-10_Chapter_D_34c1.html" title="ICD-10 Chapter D">D</a><a href="http://www.who.int/classifications/apps/icd/icd10online/?gd65.htm+d688" class="external text" title="http://www.who.int/classifications/apps/icd/icd10online/?gd65.htm+d688" rel="nofollow">68.8</a> (<a href="../../../i/l/d/ILDS_8733.html" title="ILDS">ILDS</a> D68.810)</td>
</tr>
<tr>
<th><a href="../../../o/m/i/OMIM_6457.html" title="OMIM">OMIM</a></th>
<td><a href="http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=107320" class="external text" title="http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=107320" rel="nofollow">107320</a></td>
</tr>
<tr>
<th><a href="../../../d/i/s/Diseases_Database_9859.html" title="Diseases Database">DiseasesDB</a></th>
<td><a href="http://www.diseasesdatabase.com/ddb775.htm" class="external text" title="http://www.diseasesdatabase.com/ddb775.htm" rel="nofollow">775</a></td>
</tr>
<tr>
<th><a href="../../../e/m/e/EMedicine_a89c.html" title="EMedicine">eMedicine</a></th>
<td><a href="http://www.emedicine.com/med/topic2923.htm" class="external text" title="http://www.emedicine.com/med/topic2923.htm" rel="nofollow">med/2923</a>&#160;</td>
</tr>
</table>
<p><b>Antiphospholipid syndrome</b> (or <b>antiphospholipid <a href="../../../a/n/t/Antibody.html" title="Antibody">antibody</a> syndrome</b>) (APS) is a disorder of <a href="../../../c/o/a/Coagulation.html" title="Coagulation">coagulation</a>, which causes blood clots (<a href="../../../t/h/r/Thrombosis.html" title="Thrombosis">thrombosis</a>) in both <a href="../../../a/r/t/Artery.html" title="Artery">arteries</a> and <a href="../../../v/e/i/Vein.html" title="Vein">veins</a>, as well as pregnancy-related complications such as <a href="../../../m/i/s/Miscarriage.html" title="Miscarriage">miscarriage</a>, preterm delivery, or severe <a href="../../../p/r/e/Preeclampsia.html" title="Preeclampsia">preeclampsia</a>. The syndrome occurs due to the <a href="../../../a/u/t/Autoimmune_disorder.html" title="Autoimmune disorder">autoimmune</a> production of antiphospholipid <a href="../../../a/n/t/Antibody.html" title="Antibody">antibodies</a> (aPL). The name Antiphospholipid Syndrome is a misnomer because the target <a href="../../../a/n/t/Antigen.html" title="Antigen">antigen</a> of aPL is not <a href="../../../p/h/o/Phospholipid.html" title="Phospholipid">phospholipids</a> but actually plasma proteins that bind to phopholipids (eg: [[Î²<sub>2</sub>-glycoprotein 1]] or <a href="../../../p/r/o/Prothrombin.html" title="Prothrombin">prothrombin</a>).</p>
<p>Antiphospholipid Syndrome is sometimes <a href="../../../e/p/o/Eponym.html" title="Eponym">referred to</a> as <b><a href="../../../h/u/g/Hughes_syndrome.html" title="Hughes syndrome">Hughes syndrome</a></b> after the <a href="../../../r/h/e/Rheumatology.html" title="Rheumatology">rheumatologist</a> Dr Graham R.V. Hughes (<a href="../../../s/t/2E/St._Thomas%27_Hospital_b98c.html" title="St. Thomas' Hospital">St. Thomas' Hospital</a>, <a href="../../../l/o/n/London.html" title="London">London</a>, <a href="../../../u/n/i/United_Kingdom_5ad7.html" title="United Kingdom">UK</a>) who now works treating <a href="../../../l/u/p/Lupus.html" title="Lupus">Lupus</a> and Hughes Syndrome at the London Lupus Centre.</p>
<p>The term "Primary Antiphospholipid Syndrome" is used when APS occurs in the absence of any other autoimmune disease. APS is commonly seen in conjunction with other autoimmune diseases; the term "Secondary Antiphospholipid Syndrome" is used when APS coexists with other autoimmune diseases such as systemic lupus erythematosus (SLE) and <a href="../../../h/i/v/HIV_abc5.html" title="HIV">HIV</a>/<a href="../../../a/i/d/AIDS_b1c7.html" title="AIDS">AIDS</a>. A very rare form of APS is the Catastrophic Antiphospholipid Syndrome, in which there is multiple and rapid organ <a href="../../../t/h/r/Thrombosis.html" title="Thrombosis">thrombosis</a>/dysfunction. The catastrophic APS carries a high <a href="../../../m/o/r/Mortality.html" title="Mortality">mortality</a>.</p>
<table id="toc" class="toc" summary="Contents">
<tr>
<td>
<div id="toctitle">
<h2>Contents</h2>
</div>
<ul>
<li class="toclevel-1"><a href="#Signs_and_symptoms"><span class="tocnumber">1</span> <span class="toctext">Signs and symptoms</span></a></li>
<li class="toclevel-1"><a href="#Laboratory_Tests"><span class="tocnumber">2</span> <span class="toctext">Laboratory Tests</span></a></li>
<li class="toclevel-1"><a href="#Laboratory_Tests:_Lupus_Anticoagulant_Test"><span class="tocnumber">3</span> <span class="toctext">Laboratory Tests: Lupus Anticoagulant Test</span></a></li>
<li class="toclevel-1"><a href="#Laboratory_Tests:_Anticardiolipin_Antibodies"><span class="tocnumber">4</span> <span class="toctext">Laboratory Tests: Anticardiolipin Antibodies</span></a></li>
<li class="toclevel-1"><a href="#Diagnosis"><span class="tocnumber">5</span> <span class="toctext">Diagnosis</span></a></li>
<li class="toclevel-1"><a href="#Pathogenesis"><span class="tocnumber">6</span> <span class="toctext">Pathogenesis</span></a></li>
<li class="toclevel-1"><a href="#Treatment"><span class="tocnumber">7</span> <span class="toctext">Treatment</span></a></li>
<li class="toclevel-1"><a href="#Notable_people_with_APS"><span class="tocnumber">8</span> <span class="toctext">Notable people with APS</span></a></li>
<li class="toclevel-1"><a href="#Further_reading"><span class="tocnumber">9</span> <span class="toctext">Further reading</span></a></li>
<li class="toclevel-1"><a href="#Resources"><span class="tocnumber">10</span> <span class="toctext">Resources</span></a>
<ul>
<li class="toclevel-2"><a href="#Congresses_and_Events"><span class="tocnumber">10.1</span> <span class="toctext">Congresses and Events</span></a></li>
</ul>
</li>
</ul>
</td>
</tr>
</table>
<p><script type="text/javascript">
//<![CDATA[
 if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } 
//]]>
</script><a name="Signs_and_symptoms" id="Signs_and_symptoms"></a></p>
<h2><span class="editsection">[<a href="../../../a/n/t/Antiphospholipid_syndrome.html" title="Edit section: Signs and symptoms">edit</a>]</span> <span class="mw-headline">Signs and symptoms</span></h2>
<p>The presence of <i>antiphospholipid antibodies</i> (aPL) in the absence of blood clots or pregnancy-related complications does not indicate APS (see below for the diagnosis of APS).<br /></p>
<p>Antiphosphilipid syndrome can cause (<a href="../../../a/r/t/Artery.html" title="Artery">arterial</a>/<a href="../../../v/e/i/Vein.html" title="Vein">venous</a>) blood clots (in any organ system) or pregnancy-related complications (especially miscarriage in the second or third <a href="../../../t/r/i/Trimester.html" title="Trimester">trimester</a>). In APS patients, the most common venous event is deep vein thrombosis of the lower extremities (blood clot of the deep veins of the legs) and the most common arterial event is stroke.<br /></p>
<p>Other common findings, although not part of the APS Classification Criteria, are <a href="../../../t/h/r/Thrombocytopenia.html" title="Thrombocytopenia">thrombocytopenia</a> (low <a href="../../../p/l/a/Platelet.html" title="Platelet">platelet</a> count), heart valve disease, and <a href="../../../l/i/v/Livedo_reticularis.html" title="Livedo reticularis">livedo reticularis</a> (a <a href="../../../s/k/i/Skin.html" title="Skin">skin</a> condition). Some patients report <a href="../../../h/e/a/Headache.html" title="Headache">headaches</a> and migraines. Antiphospholipid Syndrome can rarely mimic Multiple Sclerosis with an estimated 10% of patients misdiagnosed.<br /></p>
<p>Very few patients with Primary APS go on to develop SLE.</p>
<p><a name="Laboratory_Tests" id="Laboratory_Tests"></a></p>
<h2><span class="editsection">[<a href="../../../a/n/t/Antiphospholipid_syndrome.html" title="Edit section: Laboratory Tests">edit</a>]</span> <span class="mw-headline">Laboratory Tests</span></h2>
<p>Antiphospholipid syndrome is tested for in the <a href="../../../l/a/b/Laboratory.html" title="Laboratory">laboratory</a> using both liquid phase coagulation assays (Lupus Anticoagulant Test) and solid phase <a href="../../../e/l/i/ELISA_6661.html" title="ELISA">ELISA</a> (Anticardiolipin Antibodies).</p>
<p>Genetic Thrombophilia is part of the differential diagnosis of APS and can coexist in some APS patients. Thus genetic thrombophilia screening can consist of:</p>
<ul>
<li>Further studies for <a href="../../../f/a/c/Factor_V_Leiden_b1e1.html" title="Factor V Leiden">Factor V Leiden</a> variant and the <a href="../../../t/h/r/Thrombin.html" title="Thrombin">prothrombin mutation</a>, <a href="../../../f/a/c/Factor_VIII_7236.html" title="Factor VIII">Factor VIII</a> levels, <a href="../../../m/t/h/MTHFR_2956.html" title="MTHFR">MTHFR</a> mutation.</li>
<li>Levels of <a href="../../../p/r/o/Protein_C_1c3a.html" title="Protein C">protein C</a>, free and total <a href="../../../p/r/o/Protein_S_a5ec.html" title="Protein S">protein S</a>, <a href="../../../f/a/c/Factor_VIII_7236.html" title="Factor VIII">Factor VIII</a>, <a href="../../../a/n/t/Antithrombin.html" title="Antithrombin">antithrombin</a>, <a href="../../../p/l/a/Plasminogen.html" title="Plasminogen">plasminogen</a>, <a href="../../../t/i/s/Tissue_plasminogen_activator.html" title="Tissue plasminogen activator">tissue plasminogen activator</a> (TPA) and <a href="../../../p/l/a/Plasminogen_activator_inhibitor-1.html" title="Plasminogen activator inhibitor-1">plasminogen activator inhibitor-1</a> (PAI-1)</li>
</ul>
<p>The testing of antibodies to the possible individual targets of aPL such as [[Î²<sub>2</sub>Glycoprotein 1]] and antiphosphatidyl serine is currently under debate as testing for anticardiolipin appears to be currently sensitive and specific for diagnosis of APS even though <a href="../../../c/a/r/Cardiolipin.html" title="Cardiolipin">cardiolipin</a> is not considered an invivo target for antiphospholipid antibodies.</p>
<p><a name="Laboratory_Tests:_Lupus_Anticoagulant_Test" id="Laboratory_Tests:_Lupus_Anticoagulant_Test"></a></p>
<h2><span class="editsection">[<a href="../../../a/n/t/Antiphospholipid_syndrome.html" title="Edit section: Laboratory Tests: Lupus Anticoagulant Test">edit</a>]</span> <span class="mw-headline">Laboratory Tests: Lupus Anticoagulant Test</span></h2>
<p>This is tested for by using a minimum of two coagulation tests that are phospholipid sensitive this is due to the heterogeneous nature of the lupus anticoagulant antibodies. The patient on initial screening will typically have been found to have a prolonged APTT that does not correct in an 80:20 mixture with normal human <a href="../../../b/l/o/Blood_plasma.html" title="Blood plasma">plasma</a> (50:50 mixes with normal plasma are insensitive to all but the highest antibody levels). The APTT (plus 80:20 mix), <a href="../../../d/i/l/Dilute_Russell%27s_viper_venom_time_327c.html" title="Dilute Russell's viper venom time">dilute Russell's viper venom time</a> (DRVVT), the kaolin clotting time (KCT), dilute thromboplastin time {TDT/DTT) or <a href="../../../p/r/o/Prothrombin_time.html" title="Prothrombin time">Prothrombin time</a> (using a lupus sensitive [[thromboplastin) are the principal tests used for the detection of <a href="../../../l/u/p/Lupus_anticoagulant.html" title="Lupus anticoagulant">lupus anticoagulant</a>. These tests must be carried out on a minimum of two occasions at least 6 weeks apart and be positive on each occasion demonstrating persistent positivity to allow a diagnosis of antiphospholipid syndrome. This is to prevent patients with transient positive tests (due to infection etc) being diagnosed as postive.</p>
<p>Distinguishing a lupus antibody from a specific coagulation factor inhibitor (eg: <a href="../../../f/a/c/Factor_VIII_7236.html" title="Factor VIII">Factor VIII</a>). This is normally achieved by differentiating the effects of a lupus anticoagulant on factor assays from the effects of a specific coagulation factor antibody. The lupus anticoagulant will inhibit all the contact activation pathway antibodies (<a href="../../../f/a/c/Factor_VIII_7236.html" title="Factor VIII">Factor VIII</a>, <a href="../../../f/a/c/Factor_IX_28e3.html" title="Factor IX">Factor IX</a>, <a href="../../../f/a/c/Factor_XI_8f32.html" title="Factor XI">Factor XI</a> and <a href="../../../f/a/c/Factor_XII_5139.html" title="Factor XII">Factor XII</a>). Lupus anticoagulant will also rarely cause a factor assay to give a result lower than 35 iudl (35%) where as a specific factor antibody will rarely give a result higher than 10iudl (10%). Monitoring IV anticoagulant therapy by the APTR is compromised due to the effects of the lupus anticoagulant and in these situations is generally best performed using a chromogenic assay based on the inhibition of <a href="../../../f/a/c/Factor_Xa_36bd.html" title="Factor Xa">Factor Xa</a> by <a href="../../../a/n/t/Antithrombin.html" title="Antithrombin">Antithrombin</a> in the presence of <a href="../../../h/e/p/Heparin.html" title="Heparin">Heparin</a>.</p>
<p><a name="Laboratory_Tests:_Anticardiolipin_Antibodies" id="Laboratory_Tests:_Anticardiolipin_Antibodies"></a></p>
<h2><span class="editsection">[<a href="../../../a/n/t/Antiphospholipid_syndrome.html" title="Edit section: Laboratory Tests: Anticardiolipin Antibodies">edit</a>]</span> <span class="mw-headline">Laboratory Tests: Anticardiolipin Antibodies</span></h2>
<p>These can be detected using an <a href="../../../e/l/i/ELISA_6661.html" title="ELISA">enzyme-linked immunosorbent assay</a> (ELISA) <a href="../../../i/m/m/Immunology.html" title="Immunology">immunological test</a>, which screens for the presence of anticardiolipin antibodies (ACA).</p>
<p>A <a href="../../../t/h/r/Thrombocytopenia.html" title="Thrombocytopenia">Low platelet count</a> and positivity for antibodies against Î²<sub>2</sub>-glycoprotein or <a href="../../../p/h/o/Phosphatidylserine.html" title="Phosphatidylserine">phosphatidylserine</a> may also be observed in a positive diagnosis.</p>
<p><a name="Diagnosis" id="Diagnosis"></a></p>
<h2><span class="editsection">[<a href="../../../a/n/t/Antiphospholipid_syndrome.html" title="Edit section: Diagnosis">edit</a>]</span> <span class="mw-headline">Diagnosis</span></h2>
<p>The diagnosis of APS is made in case of a clinical event (vascular thrombosis or pregnancy event) <b>and</b> repeated positive tests of aPL performed 6 weeks apart (repeat aPL testing is necessary due to the naturally occurring presence of transient low levels of aPL following infections).</p>
<p>The Updated Sapporo APS Classification Criteria are commonly used for APS diagnosis (Miyakis S, Lockshin MD, Atsumi T, Branch DW, Brey RL, et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 2006;4:295-306). Based on these criteria, APS diagnosis requires:<br />
a) <i>Vascular Thrombosis</i> (blood clots) in any organ or tissue <b>or</b> <i>Pregnancy Event</i> (one or more miscarriages after 10th week of gestation, three or more miscarriages before 10th week of gestation, or one or more premature births before 34th week of gestation due to <a href="../../../e/c/l/Eclampsia.html" title="Eclampsia">eclampsia</a>) <b>and</b><br />
b) <i>Persistenly (12 weeks apart) Positive aPL</i> (lupus anticoagulant test, moderate-to-high titer anticardiolipin antibodies, or moderate-to-high titer Î²<sub>2</sub>-glycoprotein-I antibodies).</p>
<p>The International Consensus Statement is commonly used for Catastrophic APS diagnosis (Asherson RA, Cervera R, de Groot PG, Erkan D, Boffa MC, et al. Catastrophic antiphospholipid syndrome (CAPS): International Consensus Statement on Classification Criteria and Treatment Guidelines. Lupus 2003;12:530-534). Based on this statement, Definite CAPS diagnosis requires:<br />
a) Vascular Thrombosis in three or more organs or tissues <b>and</b><br />
b) Development of manifestations simultaneously or in less than a week <b>and</b><br />
c) Evidence of small vessel thrombosis in at least one organ or tissue <b>and</b><br />
d) Laboratory confirmation of the presence of aPL.</p>
<p>Some serological tests for syphilis may be positve in aPL-positive patients (aPL bind to the lipids in the test and make it come out positive) although the more specific tests for syphilis that use recombinant antigens will be negative.</p>
<p><a name="Pathogenesis" id="Pathogenesis"></a></p>
<h2><span class="editsection">[<a href="../../../a/n/t/Antiphospholipid_syndrome.html" title="Edit section: Pathogenesis">edit</a>]</span> <span class="mw-headline">Pathogenesis</span></h2>
<p>Antiphospholipid syndrome is an <a href="../../../a/u/t/Autoimmune_disease.html" title="Autoimmune disease">autoimmune disease</a>, in which "antiphospholipid antibodies" (Anticardiolipin antibodies and Lupus anticoagulant)react against anionic <a href="../../../p/h/o/Phospholipid.html" title="Phospholipid">phospholipids</a> on <a href="../../../c/e/l/Cell_membrane.html" title="Cell membrane">cell membranes</a>. Being an <a href="../../../a/u/t/Autoimmune_disease.html" title="Autoimmune disease">autoimmune disease</a>, it is more common in women than in men. The exact <a href="../../../e/t/i/Etiology.html" title="Etiology">cause</a> is not known, but activation of the system of coagulation is evident. Clinically important antiphospholipid antibodies (those that arise as a result of the autoimmune process) are associated with thrombosis and vascular disease. The syndrome can be divided into primary (no underlying disease state) and secondary (in association with an underlying disease state) forms. The main target of anticardiolipin antibodies is [[Î²<sub>2</sub>Glycoprotein 1]] and the main target of <a href="../../../l/u/p/Lupus_anticoagulant.html" title="Lupus anticoagulant">Lupus anticoagulant</a> is <a href="../../../p/r/o/Prothrombin.html" title="Prothrombin">prothrombin</a>.</p>
<p><a name="Treatment" id="Treatment"></a></p>
<h2><span class="editsection">[<a href="../../../a/n/t/Antiphospholipid_syndrome.html" title="Edit section: Treatment">edit</a>]</span> <span class="mw-headline">Treatment</span></h2>
<p>Often, this disease is treated by giving <a href="../../../a/s/p/Aspirin.html" title="Aspirin">aspirin</a> to inhibit platelet activation, and/or <a href="../../../w/a/r/Warfarin.html" title="Warfarin">warfarin</a> as an <a href="../../../a/n/t/Anticoagulant.html" title="Anticoagulant">anticoagulant</a>. The goal of the <a href="../../../p/r/o/Prophylaxis.html" title="Prophylaxis">prophylactic</a> treatment is to maintain the patient's <a href="../../../p/r/o/Prothrombin_time.html" title="Prothrombin time">INR</a> between 2.0â3.0. It is not usually done in patients who have not had any thrombotic symptoms. During <a href="../../../p/r/e/Pregnancy.html" title="Pregnancy">pregnancy</a>, low molecular weight <a href="../../../h/e/p/Heparin.html" title="Heparin">heparin</a> is used instead of warfarin because of warfarin's <a href="../../../t/e/r/Teratogen.html" title="Teratogen">teratogenicity</a>.</p>
<p>Women with recurrent miscarriage are often advised to take aspirin and to start <a href="../../../l/o/w/Low_molecular_weight_heparin.html" title="Low molecular weight heparin">low molecular weight heparin</a> treatment after missing a <a href="../../../m/e/n/Menstrual_cycle.html" title="Menstrual cycle">period</a>. This is the most effective treatment at the moment.</p>
<p><a name="Notable_people_with_APS" id="Notable_people_with_APS"></a></p>
<h2><span class="editsection">[<a href="../../../a/n/t/Antiphospholipid_syndrome.html" title="Edit section: Notable people with APS">edit</a>]</span> <span class="mw-headline">Notable people with APS</span></h2>
<p><a href="../../../a/n/n/Anne_of_Great_Britain_81c8.html" title="Anne of Great Britain">Anne of Great Britain</a> INR goal is 3.0 to 4.0 not 2.0-3.0 (Jon D. Horton, Bruce M. Bushwick. Warfarin therapy: Evolving strategies in anticoagulation)</p>
<p><a name="Further_reading" id="Further_reading"></a></p>
<h2><span class="editsection">[<a href="../../../a/n/t/Antiphospholipid_syndrome.html" title="Edit section: Further reading">edit</a>]</span> <span class="mw-headline">Further reading</span></h2>
<ul>
<li>Triona Holden. "Positive Options for Antiphospholipid Antibody Syndrome" <a href="../../../b/o/o/Special%7EBooksources_ed7b.html" class="internal">ISBN 0-89793-409-1</a>.</li>
<li>Kay Thackray. <i>Sticky Blood</i>. <a href="../../../b/o/o/Special%7EBooksources_ed7b.html" class="internal">ISBN 1-898030-77-4</a>. A personal account of dealing with the condition.</li>
</ul>
<p><a name="Resources" id="Resources"></a></p>
<h2><span class="editsection">[<a href="../../../a/n/t/Antiphospholipid_syndrome.html" title="Edit section: Resources">edit</a>]</span> <span class="mw-headline">Resources</span></h2>
<ul>
<li><a href="http://www.apsfa.org" class="external text" title="http://www.apsfa.org" rel="nofollow">APS Foundation of America, Inc.</a></li>
<li><a href="http://www.apsforum.com/" class="external text" title="http://www.apsforum.com/" rel="nofollow">APS Friends &amp; Support Forum</a></li>
<li><a href="http://rarediseasesnetwork.epi.usf.edu/rtdc/learnmore/index.htm#aps" class="external text" title="http://rarediseasesnetwork.epi.usf.edu/rtdc/learnmore/index.htm#aps" rel="nofollow">Rare Thrombotic Diseases Consortium (RTDC)</a></li>
<li><a href="http://www.apscore.org" class="external text" title="http://www.apscore.org" rel="nofollow">Antiphospholipid Syndrome Collaborative Registry (APSCORE)</a></li>
<li><a href="http://www.lupus-support.org.uk/" class="external text" title="http://www.lupus-support.org.uk/" rel="nofollow">Lupus Patients Understanding &amp; Support</a></li>
<li><a href="http://www.lupusuk.org.uk" class="external text" title="http://www.lupusuk.org.uk" rel="nofollow">Lupus UK</a></li>
<li><a href="http://www.womens-health.co.uk/antiphos.asp" class="external text" title="http://www.womens-health.co.uk/antiphos.asp" rel="nofollow">Women's health</a></li>
<li><a href="http://www.lgfellowship.org/" class="external text" title="http://www.lgfellowship.org/" rel="nofollow">Louise Gergel Fellowship - Charity funding research into Hughes Syndrome</a></li>
<li><a href="http://www.hughes-syndrome.org" class="external text" title="http://www.hughes-syndrome.org" rel="nofollow">Hughes Syndrome Foundation</a></li>
<li><a href="http://www.hygeia.org/poems4.htm" class="external text" title="http://www.hygeia.org/poems4.htm" rel="nofollow">Association with pregnancy loss</a></li>
<li><a href="http://www.londonlupuscentre.co.uk" class="external text" title="http://www.londonlupuscentre.co.uk" rel="nofollow">The London Lupus Centre</a></li>
<li><a href="http://www.antiphospholipid.net" class="external text" title="http://www.antiphospholipid.net" rel="nofollow">Antiphospholid.net</a></li>
</ul>
<p><a name="Congresses_and_Events" id="Congresses_and_Events"></a></p>
<h3><span class="editsection">[<a href="../../../a/n/t/Antiphospholipid_syndrome.html" title="Edit section: Congresses and Events">edit</a>]</span> <span class="mw-headline">Congresses and Events</span></h3>
<ul>
<li><a href="http://www.antiphospholipid.net/congress.html" class="external text" title="http://www.antiphospholipid.net/congress.html" rel="nofollow">12th International Congress on Antiphospholipid Antibodies</a></li>
<li><a href="http://www.antiphospholipid.net/patients.html" class="external text" title="http://www.antiphospholipid.net/patients.html" rel="nofollow">Conference for patients</a></li>
</ul>

<!-- 
Pre-expand include size: 4544 bytes
Post-expand include size: 2165 bytes
Template argument size: 460 bytes
Maximum: 2048000 bytes
-->
<div class="printfooter">
Retrieved from "<a href="http://en.wikipedia.org../../../a/n/t/Antiphospholipid_syndrome.html">http://en.wikipedia.org../../../a/n/t/Antiphospholipid_syndrome.html</a>"</div>
	    <div id="catlinks"><p class='catlinks'><a href="../../../c/a/t/Special%7ECategories_101d.html" title="Special:Categories">Categories</a>: <span dir='ltr'><a href="../../../a/r/t/Category%7EArticles_lacking_sources_from_March_2007_95ed.html" title="Category:Articles lacking sources from March 2007">Articles lacking sources from March 2007</a></span> | <span dir='ltr'><a href="../../../a/l/l/Category%7EAll_articles_lacking_sources_2aee.html" title="Category:All articles lacking sources">All articles lacking sources</a></span> | <span dir='ltr'><a href="../../../b/l/o/Category%7EBlood_disorders_f7e0.html" title="Category:Blood disorders">Blood disorders</a></span> | <span dir='ltr'><a href="../../../r/h/e/Category%7ERheumatology_bd39.html" title="Category:Rheumatology">Rheumatology</a></span> | <span dir='ltr'><a href="../../../h/e/m/Category%7EHematology_8cf0.html" title="Category:Hematology">Hematology</a></span> | <span dir='ltr'><a href="../../../a/u/t/Category%7EAutoimmune_diseases_6585.html" title="Category:Autoimmune diseases">Autoimmune diseases</a></span> | <span dir='ltr'><a href="../../../n/e/u/Category%7ENeurology_7728.html" title="Category:Neurology">Neurology</a></span> | <span dir='ltr'><a href="../../../o/b/s/Category%7EObstetrics_857d.html" title="Category:Obstetrics">Obstetrics</a></span> | <span dir='ltr'><a href="../../../s/y/n/Category%7ESyndromes_0e61.html" title="Category:Syndromes">Syndromes</a></span></p></div>	    <!-- end content -->
	    <div class="visualClear"></div>
	  </div>
	</div>
      </div>
      <div id="column-one">
	<div id="p-cactions" class="portlet">
	  <h5>Views</h5>
	  <ul>
	    <li id="ca-nstab-main"
	       class="selected"	       ><a href="../../../a/n/t/Antiphospholipid_syndrome.html">Article</a></li><li id="ca-talk"
	       	       ><a href="../../../a/n/t/Talk%7EAntiphospholipid_syndrome_f693.html">Discussion</a></li><li id="ca-current"
	       	       ><a href="http://en.wikipedia.org/wiki/Antiphospholipid_syndrome">Current revision</a></li>	  </ul>
	</div>
	<div class="portlet" id="p-logo">
	  <a style="background-image: url(../../../images/wiki-en.png);"
	    href="../../../index.html"
	    title="Main Page"></a>
	</div>
	<script type="text/javascript"> if (window.isMSIE55) fixalpha(); </script>
		<div class='portlet' id='p-navigation'>
	  <h5>Navigation</h5>
	  <div class='pBody'>
	    <ul>
	    	      <li id="n-Main-page"><a href="../../../index.html">Main page</a></li>
	     	      <li id="n-Contents"><a href="../../../c/o/n/Wikipedia%7EContents_3181.html">Contents</a></li>
	     	      <li id="n-Featured-content"><a href="../../../f/e/a/Wikipedia%7EFeatured_content_24ba.html">Featured content</a></li>
	     	      <li id="n-currentevents"><a href="../../../c/u/r/Portal%7ECurrent_events_bb60.html">Current events</a></li>
	     	    </ul>
	  </div>
	</div>
		<div class='portlet' id='p-interaction'>
	  <h5>interaction</h5>
	  <div class='pBody'>
	    <ul>
	    	      <li id="n-About-Wikipedia"><a href="../../../a/b/o/Wikipedia%7EAbout_8d82.html">About Wikipedia</a></li>
	     	      <li id="n-portal"><a href="../../../c/o/m/Wikipedia%7ECommunity_Portal_6a3c.html">Community portal</a></li>
	     	      <li id="n-contact"><a href="../../../c/o/n/Wikipedia%7EContact_us_afd6.html">Contact us</a></li>
	     	      <li id="n-sitesupport"><a href="http://wikimediafoundation.org/wiki/Fundraising">Make a donation</a></li>
	     	      <li id="n-help"><a href="../../../c/o/n/Help%7EContents_22de.html">Help</a></li>
	     	    </ul>
	  </div>
	</div>
		<div id="p-search" class="portlet">
	  <h5><label for="searchInput">Search</label></h5>
	  <div id="searchBody" class="pBody">
	    <form action="javascript:goToStatic(3)" id="searchform"><div>
	      <input id="searchInput" name="search" type="text"
	        accesskey="f" value="" />
	      <input type='submit' name="go" class="searchButton" id="searchGoButton"
	        value="Go" />
	    </div></form>
	  </div>
	</div>
	<div id="p-lang" class="portlet">
	  <h5>In other languages</h5>
	  <div class="pBody">
	    <ul>
	      	      <li>
	      <a href="../../../../de/a/n/t/Antiphospholipid-Syndrom_bf8e.html">Deutsch</a>
	      </li>
	      	      <li>
	      <a href="../../../../id/s/i/n/Sindrom_antibodi_antifosfolipid.html">Bahasa Indonesia</a>
	      </li>
	      	      <li>
	      <a href="../../../../ja/%E6%8A%97/%E3%83%AA/%E3%83%B3/%E6%8A%97%E3%83%AA%E3%83%B3%E8%84%82%E8%B3%AA%E6%8A%97%E4%BD%93%E7%97%87%E5%80%99%E7%BE%A4.html">æ¥æ¬èª</a>
	      </li>
	      	      <li>
	      <a href="../../../../pl/z/e/s/Zesp%C3%B3%C5%82_antyfosfolipidowy.html">Polski</a>
	      </li>
	      	    </ul>
	  </div>
	</div>
	      </div><!-- end of the left (by default at least) column -->
      <div class="visualClear"></div>
      <div id="footer">
    <div id="f-poweredbyico"><a href="http://www.mediawiki.org/"><img src="../../../skins/common/images/poweredby_mediawiki_88x31.png" alt="Powered by MediaWiki" /></a></div>	<div id="f-copyrightico"><a href="http://wikimediafoundation.org/"><img src="../../../images/wikimedia-button.png" border="0" alt="Wikimedia Foundation"/></a></div>	<ul id="f-list">
	  	  	  <li id="f-credits">This page was last modified 15:52, 30 March 2007 by Wikipedia user <a href="../../../r/a/g/User%7ERage_italic_7f1a.html" title="User:Rage italic">Rage italic</a>. Based on work by Wikipedia user(s) <a href="../../../d/o/1/User%7EDO11.10_882e.html" title="User:DO11.10">DO11.10</a>, Renji143, <a href="../../../m/h/k/User%7EMhking_b8d7.html" title="User:Mhking">Mhking</a>, <a href="../../../s/m/a/User%7ESmackBot_cc7a.html" title="User:SmackBot">SmackBot</a>, <a href="../../../t/r/a/User%7ETravislangley_ec87.html" title="User:Travislangley">Travislangley</a>, Kandersonhornblower, <a href="../../../d/r/e/User%7EDreadpiratetif_7211.html" title="User:Dreadpiratetif">Dreadpiratetif</a>, <a href="../../../g/a/i/User%7EGaius_Cornelius_c35a.html" title="User:Gaius Cornelius">Gaius Cornelius</a>, Apsaps, Ironsman, <a href="../../../r/e/n/User%7ERenice_8358.html" title="User:Renice">Renice</a>, R sirahata, <a href="../../../b/r/i/User%7EBrighterorange_f618.html" title="User:Brighterorange">Brighterorange</a>, Eyzrbrn, <a href="../../../e/l/o/User%7EElonka_d4b2.html" title="User:Elonka">Elonka</a>, <a href="../../../a/l/p/User%7EAlpinist_b424.html" title="User:Alpinist">Alpinist</a>, <a href="../../../j/a/p/User%7EJapanese_Searobin_fc2d.html" title="User:Japanese Searobin">Japanese Searobin</a>, <a href="../../../b/l/u/User%7EBluebot_e595.html" title="User:Bluebot">Bluebot</a>, <a href="../../../y/u/r/User%7EYurikBot_b393.html" title="User:YurikBot">YurikBot</a>, <a href="../../../c/o/p/User%7ECopperKettle_9495.html" title="User:CopperKettle">CopperKettle</a>, <a href="../../../j/w/i/User%7EJwinius_b7e0.html" title="User:Jwinius">Jwinius</a>, Scottybowl, <a href="../../../e/k/e/User%7EEkem_3ee4.html" title="User:Ekem">Ekem</a>, <a href="../../../r/i/c/User%7ERich_Farmbrough_7642.html" title="User:Rich Farmbrough">Rich Farmbrough</a>, <a href="../../../t/h/b/User%7ETHB_9e7b.html" title="User:THB">THB</a>, <a href="../../../a/r/c/User%7EArcadian_5c4b.html" title="User:Arcadian">Arcadian</a>, <a href="../../../b/r/a/User%7EBrandmeister_dd66.html" title="User:Brandmeister">Brandmeister</a>, <a href="../../../b/o/r/User%7EBorgx_25f8.html" title="User:Borgx">Borgx</a>, <a href="../../../j/f/d/User%7EJfdwolff_9ea6.html" title="User:Jfdwolff">Jfdwolff</a>, Sallymcvegas, Round Earther, <a href="../../../c/m/d/User%7ECmdrjameson_3c06.html" title="User:Cmdrjameson">Cmdrjameson</a>, <a href="../../../g/r/a/User%7EGrace_Note_02ea.html" title="User:Grace Note">Grace Note</a>, <a href="../../../a/r/t/User%7EArt_Carlson_64f0.html" title="User:Art Carlson">Art Carlson</a>, <a href="../../../s/a/m/User%7ESam_Hocevar_dccf.html" title="User:Sam Hocevar">Sam Hocevar</a>, <a href="../../../a/l/e/User%7EAlex.tan_6c56.html" title="User:Alex.tan">Alex.tan</a>, <a href="../../../u/n/c/User%7EUncle_G_0090.html" title="User:Uncle G">Uncle G</a>, <a href="../../../c/d/n/User%7ECDN99_e864.html" title="User:CDN99">CDN99</a>, <a href="../../../n/i/c/User%7ENickj_5f86.html" title="User:Nickj">Nickj</a>, Infotech, <a href="../../../k/s/h/User%7EKsheka_e2cf.html" title="User:Ksheka">Ksheka</a> and <a href="../../../t/r/i/User%7ETristanb_d761.html" title="User:Tristanb">Tristanb</a> and Anonymous user(s) of Wikipedia.</li>	  <li id="f-copyright">All text is available under the terms of the <a class='internal' href="../../../t/e/x/Wikipedia%7EText_of_the_GNU_Free_Documentation_License_702a.html" title="Wikipedia:Text of the GNU Free Documentation License">GNU Free Documentation License</a>. (See <b><a class='internal' href="../../../c/o/p/Wikipedia%7ECopyrights_92c4.html" title="Wikipedia:Copyrights">Copyrights</a></b> for details.) <br /> Wikipedia&reg; is a registered trademark of the <a href="http://www.wikimediafoundation.org">Wikimedia Foundation, Inc</a>., a US-registered <a class='internal' href="../../../5/0/1/501%28c%29.html#501.28c.29.283.29" title="501(c)(3)">501(c)(3)</a> <a href="http://wikimediafoundation.org/wiki/Deductibility_of_donations">tax-deductible</a> <a class='internal' href="../../../n/o/n/Non-profit_organization.html" title="Non-profit organization">nonprofit</a> <a href="../../../c/h/a/Charitable_organization.html" title="Charitable organization">charity</a>.<br /></li>	  <li id="f-about"><a href="../../../a/b/o/Wikipedia%7EAbout_8d82.html" title="Wikipedia:About">About Wikipedia</a></li>	  <li id="f-disclaimer"><a href="../../../g/e/n/Wikipedia%7EGeneral_disclaimer_3e44.html" title="Wikipedia:General disclaimer">Disclaimers</a></li>	  	</ul>
      </div>
    </div>
  </body>
</html>
